JCMVX | VMVAX | JCMVX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 13 years | - |
Gain YTD | 12.224 | 14.332 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.9B | 30.5B | 46% |
Annual Yield % from dividends | 0.46 | 2.14 | 22% |
Returns for 1 year | 16.17 | 21.85 | 74% |
Returns for 3 years | -11.15 | 17.61 | -63% |
Returns for 5 years | 0.99 | 48.02 | 2% |
Returns for 10 years | 2.68 | 96.75 | 3% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FNOV | 46.93 | 0.01 | +0.02% |
FT Cboe Vest US Equity Buffer ETF Nov | |||
RUNN | 32.73 | -0.09 | -0.27% |
Running Oak Efficient Growth ETF | |||
CGGR | 33.58 | -0.13 | -0.39% |
Capital Group Growth ETF | |||
TYD | 28.82 | -0.44 | -1.50% |
Direxion Daily 7-10 Yr Trs Bull 3X ETF | |||
CNCR | 15.40 | -0.25 | -1.60% |
Range Cancer Therapeutics ETF |